NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
Research and development spending
3Y CAGR
+17.8%/yr
Annual compound
5Y CAGR
+95.7%/yr
Recent deceleration
Percentile
P60
Within normal range
vs 5Y Ago
28.7x
Strong expansion
Streak
2 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $141.83M | -6.3% |
| 2024 | $151.41M | -5.0% |
| 2023 | $159.42M | +83.8% |
| 2022 | $86.74M | +199.4% |
| 2021 | $28.97M | +486.4% |
| 2020 | $4.94M | - |